Medtronic is a new business partner to supply insulin pumps
Medtronic, Inc., a medical device manufacturer and technology innovator, recently announced it is partnering with the National Institute of Health to supply insulin pumps. The partnership will allow Medtronic to supply insulin pumps to people with diabetes who may not have access to them otherwise.
The demand for insulin pumps, which help people with Type 1 Diabetes regulate their blood sugar, has been growing over the years due to the rising number of people living with the condition. According to the American Diabetes Association, more than 7 million people in the United States alone have diabetes. This makes access to insulin pumps even more important.
Medtronic’s new initiative will provide hundreds of thousands of individuals with access to reliable and advanced insulin pumps, ensuring they can better manage their diabetes. Through this collaboration between Medtronic and NIH, individuals with type 1 diabetes will be able to gain access to these devices at a lower cost.
In addition, Medtronic is planning to use its existing technologies, such as artificial intelligence and machine learning, to make more advanced insulin pumps available for people with diabetes who are unable to purchase one on their own. This could potentially revolutionize how individuals manage their diabetes, resulting in improved health outcomes for those affected.
Medtronic’s new partnership is a major step forward in improving healthcare for those affected by diabetes. It will give those who cannot afford an insulin pump or do not have insurance, access to this life-changing device. This is a testament to Medtronic’s commitment to using technology to make a real difference in the lives of those living with chronic conditions like diabetes.
Medtronic is an exciting new business partner that is helping to provide people with a pathway to better diabetes management and care. The company recently announced a partnership with major insulin pump manufacturers across the United States and Canada to provide a comprehensive portfolio of insulin pumps. The goal is to make it easier for people living with diabetes to manage their condition day-to-day.
As part of this multi-million-dollar collaboration, Medtronic will be supplying innovative insulin pump technology to support healthcare systems that are increasingly called upon to manage diabetes and its complications. Over the past decade, device-based therapies and approaches for treating diabetes have increased in importance due to enhanced insights into individual care needs. Medtronic’s team of experts specialize in developing tailored insulin therapy programs that can improve the lives of those with diabetes.
The Medtronic team is looking forward to working together with these leading insulin pump manufacturers, offering new and diverse technological advances for improved patient access. The comprehensive portfolio of insulin pumps will include both discreet, wearable devices as well as larger, more traditional pumps that require a separate controller. These technologies will allow healthcare providers to offer a wide range of options that cater to the specific needs and lifestyles of those living with diabetes.
The aim of this partnership is to raise the standard of diabetes management within the healthcare system and give people suffering from this condition better access to cutting-edge technology. Medtronic hopes that this expansion will make life easier for people affected by diabetes and help them take more control over their condition.